Neumora Therapeutics

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell NMRA and other ETFs, options, and stocks.

About NMRA

Neumora Therapeutics, Inc. is a clinical-stage biotechnology company. It offers a precision medicine approach for brain diseases through the integration of data science and neuroscience.

CEO

Paul L. Berns

CEOPaul L. Berns

Employees

110

Employees110

Headquarters

Watertown, Massachusetts

HeadquartersWatertown, Massachusetts

Founded

2019

Founded2019

Employees

110

Employees110

NMRA Key Statistics

Market cap

124.89M

Market cap124.89M

Price-Earnings ratio

-0.47

Price-Earnings ratio-0.47

Dividend yield

—

Dividend yield—

Average volume

1.65M

Average volume1.65M

High today

$0.8174

High today$0.8174

Low today

$0.7569

Low today$0.7569

Open price

$0.7911

Open price$0.7911

Volume

10.84M

Volume10.84M

52 Week high

$17.19

52 Week high$17.19

52 Week low

$0.611

52 Week low$0.611

Analyst ratings

57%

of 7 ratings

Buy

42.9%

Hold

57.1%

Sell

People also own

Based on the portfolios of people who own NMRA. This list is generated using Robinhood data, and it’s not a recommendation.